Thought LeadersEdoardo FabiniPrincipal Scientist Evotec U.K. G-protein-coupled receptors (GPCRs) play a pivotal role in cellular signaling and have long been a major focus in drug discovery.

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

Machine learning and supercomputing have brought about a revolution in computational drug discovery. More therapeutic candidates, like antibodies that bind to and fight the SARS-CoV-2 virus, can be ...

A research team has pioneered a groundbreaking method that could accelerate drug discovery and reduce pharmaceutical ... growing area in pharmaceutical science known as DNA-encoded library ...

Belfast drug discovery start-up Amply raises £900,000 in fundingOpens in new window Amply - which was founded by leading computational biology scientist Dr Ben Thomas, Dermot Tierney and Prof ...

Presentations highlight cutting-edge research in mitochondrial and neurodegeneration medicine, neurodegeneration, ...

Eikon Therapeutics, Inc., a late-stage clinical biopharmaceutical company dedicated to integrating advanced engineering with traditional biology research to accelerate drug discovery, today announced ...

ATX-559, a first-in-class oral DHX9 inhibitor, is being evaluated in a Phase 1/2 study with a focuson advanced or metastatic ...

Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

Another factor that may be contributing to the decline in publishing by industry medicinal chemists is the fact that ...

Fill out the form below and we'll send your colleague an invitation to the "Advances in Target-Based Drug Discovery: A Spotlight on Optical Biosensors" event. Optical biosensors are transforming how ...